Review



e coli atcc baa 204  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    ATCC e coli atcc baa 204
    Antibacterial activity of BLLT1 against ESBL-E pathogens.
    E Coli Atcc Baa 204, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli atcc baa 204/product/ATCC
    Average 93 stars, based on 3 article reviews
    e coli atcc baa 204 - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli"

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    Journal: Antibiotics

    doi: 10.3390/antibiotics13100924

    Antibacterial activity of BLLT1 against ESBL-E pathogens.
    Figure Legend Snippet: Antibacterial activity of BLLT1 against ESBL-E pathogens.

    Techniques Used: Activity Assay

    BLLT1 inhibits TLR4 mRNA expression induced by ESBL-E in HT-29 enterocytes.
    Figure Legend Snippet: BLLT1 inhibits TLR4 mRNA expression induced by ESBL-E in HT-29 enterocytes.

    Techniques Used: Expressing, Control

    BLLT1 protects the barrier function in HT-29 enterocyte monolayers from destruction by ESBL-E pathogens.
    Figure Legend Snippet: BLLT1 protects the barrier function in HT-29 enterocyte monolayers from destruction by ESBL-E pathogens.

    Techniques Used: Control

    BLLT1 inhibits paracellular permeability induced by ESBL-E strains in the HT-29 enterocyte monolayers.
    Figure Legend Snippet: BLLT1 inhibits paracellular permeability induced by ESBL-E strains in the HT-29 enterocyte monolayers.

    Techniques Used: Permeability, Control

    BLLT1 inhibits zonulin secretion induced by ESBL-E-producing strains in the enterocyte monolayers HT-29.
    Figure Legend Snippet: BLLT1 inhibits zonulin secretion induced by ESBL-E-producing strains in the enterocyte monolayers HT-29.

    Techniques Used: Control

    Effect of BLLT1 on IAP mRNA expression in enterocytes.
    Figure Legend Snippet: Effect of BLLT1 on IAP mRNA expression in enterocytes.

    Techniques Used: Expressing, Control

    Bacteria used in this study and growth conditions.
    Figure Legend Snippet: Bacteria used in this study and growth conditions.

    Techniques Used: Bacteria



    Similar Products

    e coli atcc baa 204  (ATCC)
    93
    ATCC e coli atcc baa 204
    Antibacterial activity of BLLT1 against ESBL-E pathogens.
    E Coli Atcc Baa 204, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli atcc baa 204/product/ATCC
    Average 93 stars, based on 1 article reviews
    e coli atcc baa 204 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    atcc baa 204 shv 2  (ATCC)
    93
    ATCC atcc baa 204 shv 2
    Antibacterial activity of BLLT1 against ESBL-E pathogens.
    Atcc Baa 204 Shv 2, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/atcc baa 204 shv 2/product/ATCC
    Average 93 stars, based on 1 article reviews
    atcc baa 204 shv 2 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    e coli  (ATCC)
    93
    ATCC e coli
    Antibacterial activity of BLLT1 against ESBL-E pathogens.
    E Coli, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli/product/ATCC
    Average 93 stars, based on 1 article reviews
    e coli - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    baa 204 esbl type shv 2  (ATCC)
    93
    ATCC baa 204 esbl type shv 2
    Microorganisms used in this study.
    Baa 204 Esbl Type Shv 2, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/baa 204 esbl type shv 2/product/ATCC
    Average 93 stars, based on 1 article reviews
    baa 204 esbl type shv 2 - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Antibacterial activity of BLLT1 against ESBL-E pathogens.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: Antibacterial activity of BLLT1 against ESBL-E pathogens.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Activity Assay

    BLLT1 inhibits TLR4 mRNA expression induced by ESBL-E in HT-29 enterocytes.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: BLLT1 inhibits TLR4 mRNA expression induced by ESBL-E in HT-29 enterocytes.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Expressing, Control

    BLLT1 protects the barrier function in HT-29 enterocyte monolayers from destruction by ESBL-E pathogens.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: BLLT1 protects the barrier function in HT-29 enterocyte monolayers from destruction by ESBL-E pathogens.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Control

    BLLT1 inhibits paracellular permeability induced by ESBL-E strains in the HT-29 enterocyte monolayers.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: BLLT1 inhibits paracellular permeability induced by ESBL-E strains in the HT-29 enterocyte monolayers.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Permeability, Control

    BLLT1 inhibits zonulin secretion induced by ESBL-E-producing strains in the enterocyte monolayers HT-29.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: BLLT1 inhibits zonulin secretion induced by ESBL-E-producing strains in the enterocyte monolayers HT-29.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Control

    Effect of BLLT1 on IAP mRNA expression in enterocytes.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: Effect of BLLT1 on IAP mRNA expression in enterocytes.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Expressing, Control

    Bacteria used in this study and growth conditions.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: Bacteria used in this study and growth conditions.

    Article Snippet: E. coli ATCC BAA 204 , 1.6 ± 0.3 , 1.5 ± 0.2 * , 15 ± 2 ** , 1.7 ± 0.3 *.

    Techniques: Bacteria

    Antibacterial activity of BLLT1 against ESBL-E pathogens.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: Antibacterial activity of BLLT1 against ESBL-E pathogens.

    Article Snippet: E. coli , ATCC BAA 204 SHV-2 , The same.

    Techniques: Activity Assay

    Bacteria used in this study and growth conditions.

    Journal: Antibiotics

    Article Title: A Novel Bifidobacterium longum Subsp. longum T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing Escherichia coli

    doi: 10.3390/antibiotics13100924

    Figure Lengend Snippet: Bacteria used in this study and growth conditions.

    Article Snippet: E. coli , ATCC BAA 204 SHV-2 , The same.

    Techniques: Bacteria

    Microorganisms used in this study.

    Journal: Antibiotics

    Article Title: Limosilactobacillus fermentum Strain 3872: Antibacterial and Immunoregulatory Properties and Synergy with Prebiotics against Socially Significant Antibiotic-Resistant Infections of Animals and Humans

    doi: 10.3390/antibiotics11101437

    Figure Lengend Snippet: Microorganisms used in this study.

    Article Snippet: E. coli , ATCC BAA 204 ESBL Type SHV-2 , The same.

    Techniques: